A Predictive Model for Clinical Asthma Exacerbations Using Albuterol eMDPI (ProAir Digihaler): A 12-Week, Open-Label Study

被引：0
|
作者：
Safioti, G. [1 ]
Granovsky, L. [2 ]
Li, T. [3 ]
Reich, M. [2 ]
Cohen, S. [4 ]
Hadar, Y. [4 ]
Pleasants, R. [5 ]
Hill, T. [3 ]
DePietro, M. [3 ]
机构：
[1] Teva Pharmaceut, Amsterdam, Netherlands
[2] Teva Pharmaceut Ltd, Petah Tiqwa, Israel
[3] Teva Branded Pharmaceut R&D Inc, Malvern, PA USA
[4] Yellow Rd, Petah Tiqwa, Israel
[5] Univ N Carolina, Sch Med, Div Pulm Med & Crit Care, Chapel Hill, NC 27515 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7307
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Predictive Model for COPD Exacerbations Using ProAir Digihaler: A 12-Week, Open-Label Study
    Snyder, L. D.
    Safioti, G.
    Reich, M.
    Neely, M.
    Lugogo, N.
    Pleasants, R. A.
    Li, T.
    Granovsky, L.
    DePietro, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [2] Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
    Morillas-Arques, Piedad
    Ma Rodriguez-Lopez, Carmen
    Molina-Barea, Rocio
    Rico-Villademoros, Fernando
    Calandre, Elena P.
    BMC MUSCULOSKELETAL DISORDERS, 2010, 11
  • [3] Trazodone for the treatment of fibromyalgia: an open-label, 12-week study
    Piedad Morillas-Arques
    Carmen Ma Rodriguez-Lopez
    Rocio Molina-Barea
    Fernando Rico-Villademoros
    Elena P Calandre
    BMC Musculoskeletal Disorders, 11
  • [4] A Predictive Machine Learning Tool for Asthma Exacerbations: Results from a 12-Week, Open-Label Study Using an Electronic Multi-Dose Dry Powder Inhaler with Integrated Sensors
    Lugogo, Njira L.
    DePietro, Michael
    Reich, Michael
    Merchant, Rajan
    Chrystyn, Henry
    Pleasants, Roy
    Granovsky, Lena
    Li, Thomas
    Hill, Tanisha
    Brown, Randall W.
    Safioti, Guilherme
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 1623 - 1637
  • [5] Agomelatine in the Treatment of Fibromyalgia A 12-Week, Open-Label, Uncontrolled Preliminary Study
    Bruno, Antonio
    Mico, Umberto
    Lorusso, Simona
    Cogliandro, Nadia
    Pandolfo, Gianluca
    Caminiti, Maurizio
    Zoccali, Rocco A.
    Muscatello, Maria R. A.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (04) : 507 - 511
  • [6] A 12-Week, Open-Label Study Evaluating Sodium Oxybate (SXB) in Patients with Narcolepsy
    Mamelak, Mortimer
    Swick, Todd
    Emsellem, Helene
    Montplaisir, Jacques
    Lai, Chinglin
    Black, Jed
    ANNALS OF NEUROLOGY, 2014, 76 : S131 - S132
  • [7] Effectiveness of a Digital Inhaler System for Patients With Asthma: A 12-Week, Open-Label, Randomized Study (CONNECT1)
    Hoyte, Flavia C. L.
    Mosnaim, Giselle S.
    Rogers, Linda
    Safioti, Guilherme
    Brown, Randall
    Li, Thomas
    DePietro, Michael
    Reich, Michael
    Hill, Tanisha D.
    Wechsler, Michael E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (10): : 2579 - 2587
  • [8] Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study
    Iyo, Masaomi
    Ishigooka, Jun
    Nakamura, Masatoshi
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Mao, Yongcai
    Tsai, Joyce
    Fitzgerald, Alison
    Takai, Kentaro
    Higuchi, Teruhiko
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 2683 - 2695
  • [9] A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients
    Graham, JA
    Ketter, TA
    Roberts, J
    DeVeaugh-Geiss, AM
    Thompson, TR
    BIPOLAR DISORDERS, 2005, 7 : 62 - 62
  • [10] Safety and Tolerability of Dextromethorphan/Quinidine for Pseudobulbar Affect in a 12-Week, Open-Label Extension Study
    Pioro, Erik
    Brooks, Benjamin
    Cummings, Jeffrey
    Schiffer, Randolph
    Wynn, Daniel
    Hepner, Adrian
    Viejo, Aliso
    Kaye, Randall
    NEUROLOGY, 2010, 74 (09) : A541 - A541
12345